Pharmacy &Therapeutics Committee Updates

(From the June 2018 Issue of MedStat)

The following actions were taken at the 4/5/18 Pharmacy & Therapeutics Committee meeting:

  • Hydroxyurea was REMOVED from the list of medications requiring ordering by an attending physician or second signature by an attending physician.
  • Changes to the IV Administration Instructions for IVIG were APPROVED.
  • Changes to the Infectious Diseases Clinic Medication Stock List were APPROVED.
  • Changes to the Nephrology Clinic Medication Stock List were APPROVED.
  • Changes to the Therapeutic Drug Monitoring Policy were APPROVED.

The following actions were taken at the 5/3/18 Pharmacy & Therapeutics Committee meeting:

  • Triazolam (Halcion) was ADDED to formulary with a restriction to use in dental clinic.
  • Brivaracitam (Briviact) was ADDED to formulary.
  • The alteplase clinic practice guideline was APPROVED.
  • Changes to the IV Administration Instructions for alteplase were APPROVED.
  • Changes to the H4A Medication Override List were APPROVED.